BioMarin's Dwarfism Therapy Gets FDA Nod for Expanded Use
By Pratik JainOctober23,2023(Reuters) - The U.S. health regulator on Friday approved the expanded use of BioMarin Pharmaceutical's once-daily injection to treat children under the age
BioMarin's Dwarfism Therapy Gets FDA Nod for Expanded Use
By Pratik JainOctober23,2023(Reuters) - The U.S. health regulator on Friday approved the expanded use of BioMarin Pharmaceutical's once-daily injection to treat children under the age